Maxcyte (MXCT) Free Cash Flow (2020 - 2026)

Maxcyte (MXCT) has 7 years of Free Cash Flow data on file, last reported at -$8.2 million in Q1 2026.

• On a quarterly basis, Free Cash Flow rose 45.29% year-over-year to -$8.2 million in Q1 2026; TTM through Mar 2026 was -$28.3 million, a 12.19% increase from a year earlier, with the FY2025 full-year figure at -$35.1 million, down 26.81% from the prior year.
• Free Cash Flow for Q1 2026 stood at -$8.2 million, down from -$2.5 million in the prior quarter.
• Over the last five years, Free Cash Flow for MXCT reached as high as $6.3 million in Q2 2022 and fell as low as -$23.7 million in Q4 2022.
• Historically, Free Cash Flow has averaged -$7.4 million across 5 years, with a median of -$7.9 million in 2024.
• On a YoY basis, Free Cash Flow climbed as much as 205.1% in 2022 and fell as far as 1037.64% in 2022.
• Year by year, Free Cash Flow stood at -$23.7 million in 2022, then jumped by 113.51% to $3.2 million in 2023, then tumbled by 346.34% to -$7.9 million in 2024, then jumped by 68.43% to -$2.5 million in 2025, then tumbled by 231.1% to -$8.2 million in 2026.
• Per Business Quant data, the three most recent Free Cash Flow figures were -$8.2 million in Q1 2026, -$2.5 million in Q4 2025, and -$7.1 million in Q3 2025.